United Orthopedic
United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments in Taiwan, Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial kn… Read more
United Orthopedic (4129) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.082x
Based on the latest financial reports, United Orthopedic (4129) has a cash flow conversion efficiency ratio of 0.082x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$328.40 Million) by net assets (NT$4.03 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
United Orthopedic - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how United Orthopedic's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
United Orthopedic Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of United Orthopedic ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ratio Oil Exploration (1992) Limited Partnership
PINK:RTEXF
|
0.072x |
|
Gansu Engineering Consulting Group Co Ltd
SHE:000779
|
0.031x |
|
EPL Limited
NSE:EPL
|
0.064x |
|
Oriental Holdings Bhd
KLSE:4006
|
0.060x |
|
BGRIMM Science and Technology Co Ltd
SHG:600980
|
0.050x |
|
Caleres Inc
NYSE:CAL
|
0.065x |
|
Ningxia Xinri Hengli Steel Wire Rope Co Ltd
SHG:600165
|
1.156x |
|
Nusantara Sawit Sejahtera
JK:NSSS
|
0.079x |
Annual Cash Flow Conversion Efficiency for United Orthopedic (2015–2024)
The table below shows the annual cash flow conversion efficiency of United Orthopedic from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$3.95 Billion | NT$717.29 Million | 0.182x | +63.81% |
| 2023-12-31 | NT$3.59 Billion | NT$398.43 Million | 0.111x | +0.51% |
| 2022-12-31 | NT$3.09 Billion | NT$340.79 Million | 0.110x | -7.03% |
| 2021-12-31 | NT$2.82 Billion | NT$334.64 Million | 0.119x | -27.95% |
| 2020-12-31 | NT$2.93 Billion | NT$481.65 Million | 0.165x | -1.89% |
| 2019-12-31 | NT$2.93 Billion | NT$492.45 Million | 0.168x | +2943.61% |
| 2018-12-31 | NT$2.25 Billion | NT$12.41 Million | 0.006x | +321.95% |
| 2017-12-31 | NT$2.22 Billion | NT$2.90 Million | 0.001x | -98.68% |
| 2016-12-31 | NT$1.80 Billion | NT$179.03 Million | 0.099x | -30.29% |
| 2015-12-31 | NT$1.77 Billion | NT$252.75 Million | 0.143x | -- |